Optimist Retirement Group LLC Has $338,000 Stake in DocuSign, Inc. (NASDAQ:DOCU)

Optimist Retirement Group LLC lessened its position in DocuSign, Inc. (NASDAQ:DOCU) by 14.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,757 shares of the company’s stock after selling 659 shares during the period. Optimist Retirement Group LLC’s holdings in DocuSign were worth $338,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of the company. Avior Wealth Management LLC increased its stake in shares of DocuSign by 36.5% in the fourth quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after buying an additional 145 shares during the period. Linden Thomas Advisory Services LLC grew its holdings in DocuSign by 1.1% during the 4th quarter. Linden Thomas Advisory Services LLC now owns 13,540 shares of the company’s stock worth $1,218,000 after acquiring an additional 149 shares during the last quarter. J.W. Cole Advisors Inc. increased its position in DocuSign by 2.0% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock valued at $493,000 after acquiring an additional 155 shares during the period. Resonant Capital Advisors LLC increased its position in DocuSign by 0.9% in the 3rd quarter. Resonant Capital Advisors LLC now owns 17,516 shares of the company’s stock valued at $1,088,000 after acquiring an additional 157 shares during the period. Finally, V Square Quantitative Management LLC raised its stake in shares of DocuSign by 6.0% during the third quarter. V Square Quantitative Management LLC now owns 3,019 shares of the company’s stock valued at $187,000 after acquiring an additional 172 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on DOCU shares. Needham & Company LLC restated a “hold” rating on shares of DocuSign in a report on Tuesday. Hsbc Global Res upgraded DocuSign to a “moderate sell” rating in a research report on Friday, December 6th. Royal Bank of Canada restated a “sector perform” rating and set a $90.00 price objective (up from $57.00) on shares of DocuSign in a research report on Friday, December 6th. HSBC reiterated a “reduce” rating on shares of DocuSign in a report on Friday, December 6th. Finally, Citigroup raised their price target on shares of DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a report on Friday, December 6th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, DocuSign presently has an average rating of “Hold” and an average target price of $92.45.

DocuSign Stock Up 0.4 %

Shares of NASDAQ DOCU opened at $96.89 on Thursday. The firm has a market cap of $19.57 billion, a PE ratio of 19.98, a P/E/G ratio of 8.74 and a beta of 0.89. The company’s fifty day simple moving average is $91.77 and its 200 day simple moving average is $73.66. DocuSign, Inc. has a 12-month low of $48.70 and a 12-month high of $107.86.

Insider Activity

In related news, CEO Allan C. Thygesen sold 7,763 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $80.54, for a total value of $625,232.02. Following the completion of the sale, the chief executive officer now directly owns 100,062 shares of the company’s stock, valued at $8,058,993.48. The trade was a 7.20 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $94.60, for a total value of $50,516.40. Following the completion of the transaction, the director now owns 7,736 shares in the company, valued at approximately $731,825.60. The trade was a 6.46 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 685,773 shares of company stock worth $66,032,726. Company insiders own 1.66% of the company’s stock.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.